SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-047784
Filing Date
2011-05-10
Accepted
2011-05-10 06:05:49
Documents
14
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f58570e10vq.htm 10-Q 462695
2 EX-10.1(I) f58570exv10w1wi.htm EX-10.1.I 345385
3 EX-10.13(V) f58570exv10w13wv.htm EX-10.13.V 56902
4 EX-10.22(II) f58570exv10w22wii.htm EX-10.22.II 47030
5 EX-31.1 f58570exv31w1.htm EX-31.1 7159
6 EX-31.2 f58570exv31w2.htm EX-31.2 7201
7 EX-32.1 f58570exv32w1.htm EX-32.1 4906
13 GRAPHIC f58570f5857000.gif GRAPHIC 1959
14 GRAPHIC f58570f5857001.gif GRAPHIC 2144
  Complete submission text file 0000950123-11-047784.txt   2466672

Data Files

Seq Description Document Type Size
8 EX-101 INSTANCE DOCUMENT onxx-20110331.xml EX-101.INS 253840
9 EX-101 SCHEMA DOCUMENT onxx-20110331.xsd EX-101.SCH 14136
10 EX-101 CALCULATION LINKBASE DOCUMENT onxx-20110331_cal.xml EX-101.CAL 37906
11 EX-101 LABELS LINKBASE DOCUMENT onxx-20110331_lab.xml EX-101.LAB 113224
12 EX-101 PRESENTATION LINKBASE DOCUMENT onxx-20110331_pre.xml EX-101.PRE 70568
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28298 | Film No.: 11825647
SIC: 2836 Biological Products, (No Diagnostic Substances)